Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira as Their First Anti-TNF Monoclonal Antibody (VIVIR).
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2009
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms VIVIR
- Sponsors Abbott Laboratories
- 20 Nov 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 30 Oct 2008 Planned end date changed from 1 May 2009 to 1 Aug 2008 as reported by ClinicalTrials.gov.
- 30 Oct 2008 Actual patient number (14) added as reported by ClinicalTrials.gov.